IRWD Historical PE Ratio image   This IRWD PE ratio history page last updated 8/8/2022
IRWD PE History Chart
PeriodPriceAdj. EPSTTMPE
Q2 2022
8/4/2022
11.480.211.0211.3
Q1 2022
5/5/2022
12.240.211.1510.6
Q4 2021
2/17/2022
10.610.271.189.0
Q3 2021
11/4/2021
12.580.331.279.9
Q2 2021
8/5/2021
13.290.341.1711.4
Q1 2021
5/6/2021
10.490.240.9910.6
Q4 2020
2/17/2021
9.730.360.7912.3
Q3 2020
11/5/2020
10.010.230.7313.7
Q2 2020
8/6/2020
10.090.160.9011.2
Q1 2020
5/6/2020
10.400.040.8412.4
Q4 2019
2/13/2020
13.070.300.5424.2
Q3 2019
10/31/2019
10.040.400.2245.6
Q2 2019
7/30/2019
10.530.10-0.56NA
Q1 2019
5/2/2019
10.27-0.26-0.94NA
Q4 2018
2/13/2019
12.35-0.02-0.95NA
Q3 2018
11/6/2018
10.70-0.38-1.07NA
Q2 2018
8/6/2018
15.39-0.28-0.87NA
Q1 2018
5/1/2018
15.65-0.27-0.87NA
Q4 2017
2/15/2018
12.98-0.14-0.93NA
Q3 2017
11/2/2017
12.71-0.18-0.91NA
Q2 2017
8/3/2017
13.94-0.28-0.91NA
Q1 2017
5/8/2017
13.18-0.33-0.79NA
Q4 2016
2/21/2017
14.34-0.12-0.54NA
Q3 2016
11/3/2016
10.63-0.18-0.52NA
Q2 2016
8/4/2016
11.86-0.16-0.59NA
Q1 2016
5/9/2016
8.56-0.08-0.77NA
Q4 2015
2/18/2016
7.19-0.10-0.93NA
Q3 2015
11/3/2015
9.63-0.25-1.10NA
Q2 2015
8/5/2015
8.98-0.34-1.15NA
Q1 2015
5/5/2015
11.30-0.24-1.25NA
Q4 2014
2/12/2015
13.40-0.27-1.39NA
Q3 2014
11/4/2014
11.34-0.30-1.55NA
Q2 2014
8/4/2014
12.44-0.44-1.76NA
Q1 2014
4/29/2014
9.47-0.38-1.89NA
Q4 2013
1/21/2014
12.35-0.43-2.38NA
Q3 2013
10/22/2013
8.45-0.51-2.36NA
Q2 2013
7/23/2013
9.46-0.57-1.43NA
Q1 2013
4/23/2013
14.05-0.87-1.24NA
Q4 2012
1/15/2013
12.30-0.41-0.71NA
Q3 2012
10/16/2012
11.110.42NANA
Q2 2012
7/17/2012
11.10-0.38NANA
Q1 2012
5/1/2012
10.85-0.34NANA
IRWD Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q2 2022
8/4/2022
11.480.210.8413.7
Q1 2022
5/5/2022
12.240.210.8414.6
Q4 2021
2/17/2022
10.610.271.089.8
Q3 2021
11/4/2021
12.580.331.329.5
Q2 2021
8/5/2021
13.290.341.369.8
Q1 2021
5/6/2021
10.490.240.9610.9
Q4 2020
2/17/2021
9.730.361.446.8
Q3 2020
11/5/2020
10.010.230.9210.9
Q2 2020
8/6/2020
10.090.160.6415.8
Q1 2020
5/6/2020
10.400.040.1665.0
Q4 2019
2/13/2020
13.070.301.2010.9
Q3 2019
10/31/2019
10.040.401.606.3
Q2 2019
7/30/2019
10.530.100.4026.3
Q1 2019
5/2/2019
10.27-0.26-1.04NA
Q4 2018
2/13/2019
12.35-0.02-0.08NA
Q3 2018
11/6/2018
10.70-0.38-1.52NA
Q2 2018
8/6/2018
15.39-0.28-1.12NA
Q1 2018
5/1/2018
15.65-0.27-1.08NA
Q4 2017
2/15/2018
12.98-0.14-0.56NA
Q3 2017
11/2/2017
12.71-0.18-0.72NA
Q2 2017
8/3/2017
13.94-0.28-1.12NA
Q1 2017
5/8/2017
13.18-0.33-1.32NA
Q4 2016
2/21/2017
14.34-0.12-0.48NA
Q3 2016
11/3/2016
10.63-0.18-0.72NA
Q2 2016
8/4/2016
11.86-0.16-0.64NA
Q1 2016
5/9/2016
8.56-0.08-0.32NA
Q4 2015
2/18/2016
7.19-0.10-0.40NA
Q3 2015
11/3/2015
9.63-0.25-1.00NA
Q2 2015
8/5/2015
8.98-0.34-1.36NA
Q1 2015
5/5/2015
11.30-0.24-0.96NA
Q4 2014
2/12/2015
13.40-0.27-1.08NA
Q3 2014
11/4/2014
11.34-0.30-1.20NA
Q2 2014
8/4/2014
12.44-0.44-1.76NA
Q1 2014
4/29/2014
9.47-0.38-1.52NA
Q4 2013
1/21/2014
12.35-0.43-1.72NA
Q3 2013
10/22/2013
8.45-0.51-2.04NA
Q2 2013
7/23/2013
9.46-0.57-2.28NA
Q1 2013
4/23/2013
14.05-0.87-3.48NA
Q4 2012
1/15/2013
12.30-0.41-1.64NA
Q3 2012
10/16/2012
11.110.421.686.6
Q2 2012
7/17/2012
11.10-0.38-1.52NA
Q1 2012
5/1/2012
10.85-0.34-1.36NA
Quotes delayed 20 minutes

Email EnvelopeFree IRWD Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Ironwood Pharmaceuticals (IRWD) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ISEE PE Ratio History
ISPC PE Ratio History
ISRG PE Ratio History
ITCI PE Ratio History
ITGR PE Ratio History
ITOS PE Ratio History
IVC PE Ratio History
JAGX PE Ratio History
JANX PE Ratio History
JAZZ PE Ratio History
On this page we presented the IRWD PE Ratio History information for Ironwood Pharmaceuticals' stock. The average IRWD PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 15.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average IRWD PE ratio history based on this TTM earnings result method is 15.2. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this IRWD PE ratio history result, against the recent PE: when this page was posted on 8/5/2022, the most recent closing price for IRWD had been 11.87, and the most recent quarterly earnings result, annualized, was 0.84. Meanwhile, the most recent TTM earnings summed to 1.02. From these numbers, we calculate the recent IRWD PE on 8/5/2022 based on annualized quarterly EPS was 14.1. Based on IRWD's history, that recent PE is low relative to the historical average, with the recent PE 9.0% lower than the historical average PE across our data set for Ironwood Pharmaceuticals. Looking at the recent IRWD PE on 8/5/2022 based on TTM EPS, we calculate the ratio at 11.6. Based on IRWD's history, that recent PE is low relative to the historical average, with the recent PE 23.7% lower than the average PE across our Ironwood Pharmaceuticals data set with TTM EPS used in the calculation at each period.

Another interesting IRWD PE ratio history calculation we look at is to take the median earnings per share of the last four quarters for IRWD, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for IRWD, we start with the past four EPS numbers and we first sort them from lowest to highest: 0.21, 0.21, 0.27, and 0.33. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 0.21 and 0.27 — which gives us the median of 0.24. Basically the way to think about this 0.24 number is this: for the trailing four earnings reports, 0.24 marks the "middle ground" number where IRWD has reported a value higher than 0.24 half the time, and has reported a value lower than 0.24 half the time. Annualizing that median value then gets us to 0.96/share, which we use as the denominator in our next PE calculation. With 11.87 as the numerator (as of 8/5/2022), the calculation is then 11.87 / 0.96 = 12.4 as the IRWD PE ratio as of 8/5/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on IRWD or any other given stock, valuation analysis for IRWD can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Ironwood Pharmaceuticals PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for IRWD. Thanks for visiting, and the next time you need to research IRWD PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: EOD Next Dividend Date, Top Ten Hedge Funds Holding FEBZ, MA Videos.

 

IRWD PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.